Existing infra for testing medical devices inadequate: Parliamentary panel

The report presented in the Parliament by a standing committee stated that along with more testing labs, the country needs a robust IT-enabled and feedback-driven post-sales surveillance system

Parliament
BS Web Team New Delhi
2 min read Last Updated : Sep 15 2022 | 10:49 AM IST

The Central Drugs Standard Control Organisation (CDSCO) is falling short in regulating the medical devices industry, and more medical device testing laboratories need to be set up, a report presented in the Parliament by the Standing Committee on Health stated. The committee was headed by Ram Gopal Yadav, a member of Parliament, as reported by The Hindu.

 

The "Medical Devices: Regulations and Control" report stated that along with more testing labs, the country needs a robust IT-enabled and feedback-driven post-sales surveillance system, The Hindu report added. 

 

The surveillance of medical devices, including implants, will help regulators to keep track of their performance. Currently, India has only 18 such regulators approved by CDSCO. 

Also Read : Panel approves 32 beneficiaries under PLI for large-scale electronics mfg

 

The committee's report focused on the fact that India lacks the research ecosystem to develop medical devices as per global standards. Also, it recommended the government start a Research Linked Incentive (RLI) scheme similar to the Production Linked Incentive (PLI) scheme to facilitate the academia-industry partnership.

 

It said that the Health Ministry must allow the regulators to include IISC, CSIR, DRDO and IITs to test the medical devices to meet the growing demand. Moreover, other institutes should be developed to enable the testing of medical devices. 

 

The need to remove the multiple regulations and set up a single window clearance platform for the application of the license for manufacturing as well as trading of these devices was also discussed in the report. 

 

"A single window clearance for all the Department/Ministries would significantly boost investment in R&D in the field of medical devices and would also reduce the time required for obtaining approvals from different Departments/Ministries. The Ministry must incorporate such an all-encompassing 'single window clearing/approval system' in the proposed new separate Act for the regulation of Medical Devices," the report added.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :DRDOBS Web ReportsParliamentMedical devicesCDSCORajya SabhaHealth MinistryPLI schemeIIScCSIRIITs

Next Story